Martin Pecherstorfer

Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies

Jean‐Jacques Body, Ingo Diel, M. Lichinitzer et al. · British Journal of Cancer · 2004 · 334 citations · Full text

Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments]

Heinz Ludwig, E. Fritz, Clemens Leitgeb et al. · Blood · 1994 · 192 citations · Full text

Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer

Jean-Jacques Body, Ingo Diel, Richard H. Bell et al. · Pain · 2004 · 189 citations

Cancer Quality, Pain Therapy, Pain Medicine +17

Novel Serum Markers of Bone Resorption: Clinical Assessment and Comparison with Established Urinary Indices

Henning W. Woitge, Martin Pecherstorfer, Yuming Li et al. · Journal of Bone and Mineral Research · 1999 · 181 citations · Full text

Interleukin-6 and tumor necrosis factor α levels after bisphosphonates treatment in vitro and in patients with malignancy

Alain Sauty, Martin Pecherstorfer, Ilse Zimmer-Roth et al. · Bone · 1996 · 177 citations

Inflammation, Translational Medicine, Bisphosphonates Treatment +3